Variant report
Variant | nsv457751 |
---|---|
Chromosome Location | chr2:52040842-52060125 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 2:51755125-51764739..2:52034460-52043624 | K562 | blood: | |
2 | 2:52043909-52049825..2:52049825-52050373 | K562 | blood: | |
3 | 2:51664217-51674289..2:52034460-52043624 | GM12878 | blood: | |
4 | chr2:52045177..52047183-chr2:52049220..52051220,2 | K562 | blood: | |
5 | chr2:52045177..52047183-chr2:52049220..52051220,2 | K562 | blood: | |
6 | chr2:52013693..52015857-chr2:52040010..52042547,2 | K562 | blood: | |
7 | 2:52043909-52049825..2:52049825-52050373 | K562 | blood: | |
8 | 2:51745267-51754233..2:52043624-52043909 | K562 | blood: | |
9 | chr2:52045177..52047313-chr2:52049220..52051486,2 | K562 | blood: | |
10 | 2:51664217-51674289..2:52055539-52058793 | H1-hESC | embryonic stem cell: | embryo |
11 | 2:51664217-51674289..2:52043909-52049825 | H1-hESC | embryonic stem cell: | embryo |
12 | chr2:52045177..52047313-chr2:52049220..52051486,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7595930 | chr2:52040842-52040843 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550070825 | chr2:52040900-52040901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190683054 | chr2:52040915-52040916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11563111 | chr2:52040927-52040928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116475174 | chr2:52040951-52040952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368848591 | chr2:52040965-52040966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138113332 | chr2:52040971-52040972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181976992 | chr2:52040993-52040994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs28966386 | chr2:52040998-52040999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78506307 | chr2:52041007-52041008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186179138 | chr2:52041015-52041016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11563261 | chr2:52041066-52041067 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs80060792 | chr2:52041067-52041068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs17864624 | chr2:52041099-52041100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189094533 | chr2:52041109-52041110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374937737 | chr2:52041199-52041200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546486987 | chr2:52041236-52041237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140397341 | chr2:52041247-52041248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547498054 | chr2:52041255-52041256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528740696 | chr2:52041280-52041281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150620359 | chr2:52041299-52041300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11563082 | chr2:52041361-52041362 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs139671500 | chr2:52041416-52041417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573821532 | chr2:52041428-52041429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372470600 | chr2:52041453-52041454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373466225 | chr2:52041456-52041457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149388268 | chr2:52041608-52041609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534721815 | chr2:52041645-52041646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565805841 | chr2:52041705-52041706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568876683 | chr2:52041710-52041711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11563110 | chr2:52041737-52041738 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs35806021 | chr2:52041786-52041787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575829448 | chr2:52041794-52041795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144731351 | chr2:52041803-52041804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544847465 | chr2:52041814-52041815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34848052 | chr2:52041827-52041828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369765822 | chr2:52041845-52041846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9309221 | chr2:52041853-52041854 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs185451432 | chr2:52041860-52041861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74320111 | chr2:52041912-52041913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28966387 | chr2:52041949-52041950 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs145540736 | chr2:52041957-52041958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189911767 | chr2:52041967-52041968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558526142 | chr2:52042014-52042015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75835763 | chr2:52042043-52042044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371272377 | chr2:52042046-52042047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543057091 | chr2:52042135-52042136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182908614 | chr2:52042144-52042145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540847522 | chr2:52042201-52042202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562112412 | chr2:52042207-52042208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52039000-52041200 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr2:52039200-52041000 | Enhancers | HMEC | breast |
3 | chr2:52039200-52041000 | Enhancers | NH-A | brain |
4 | chr2:52039200-52041200 | Enhancers | NHDF-Ad | bronchial |
5 | chr2:52039200-52041600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr2:52039200-52042400 | Enhancers | HUVEC | blood vessel |
7 | chr2:52039400-52041000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr2:52039600-52043400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr2:52039800-52041000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr2:52039800-52041600 | Enhancers | Hela-S3 | cervix |
11 | chr2:52043200-52044000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr2:52043200-52044600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr2:52043400-52044800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr2:52043600-52044600 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr2:52043600-52044600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr2:52043600-52044600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr2:52043800-52044400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr2:52044200-52044600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr2:52051800-52054000 | Enhancers | Hela-S3 | cervix |
20 | chr2:52052800-52053800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr2:52053400-52054200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr2:52053800-52054200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr2:52054200-52055000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr2:52054200-52068600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |